Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
about
Diet in the management of weight lossRole of LXRs in control of lipogenesisRole of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineInformativeness of indices of blood pressure, obesity and serum lipids in relation to ischaemic heart disease mortality: the HUNT-II studyTriglycerides as vascular risk factors: new epidemiologic insightsInforming food choices and health outcomes by use of the dietary glycemic indexRegulatory challenges for new drugs to treat obesity and comorbid metabolic disordersHypertriglyceridemia: its etiology, effects and treatmentGene therapy for lipid disordersChanges in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDSVariations in the lipid profile of patients with chronic renal failure treated with pyridoxineEffect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans.Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysisOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusA review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individualsRole of lipotoxicity in endothelial dysfunctionPreclinical and Clinical Studies on Antioxidative, Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides-A ReviewDifferential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular ComplicationsOmega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemiaNutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndromeSex differences in the pathophysiology, treatment, and outcomes in IHDA macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosisFenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemiaProtease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotypeTriacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophagesAssociation between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional studyImpaired lipid levels and inflammatory response in rats exposed to cadmiumDeterminants of aortic stiffness: 16-year follow-up of the Whitehall II studyIncreasing objectively measured sedentary time increases clustered cardiometabolic risk: a 6 year analysis of the ProActive study.Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry.Joint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia.Triglycerides and HDL cholesterol: stars or second leads in diabetes?Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus.Triglycerides and cardiovascular risk.Relationship of adiposity to the population distribution of plasma triglyceride concentrations in vigorously active men and women.Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial.Insulin resistance and triglyceride/HDLc index are associated with coronary artery diseaseCurrent status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.
P2860
Q22241396-272874B3-F6A6-4C5D-8146-01024DB17D73Q24290548-FDC624D4-93F3-4D1B-BB51-47133006A0FDQ24564203-40A5AF5C-DF71-4CBA-ADF9-9B11E7F61FFAQ24608464-03E86C58-EEC4-4F8F-8F00-391847D18B96Q24613780-56CC7029-D960-4C23-99F7-C972FD6C472BQ24618902-F1A58179-3AD0-4721-8869-583099D75F8CQ24626304-065156E7-D260-4797-A605-918529015247Q24658031-AC426A86-A8A9-4526-BA56-01FAA8217CE6Q24672914-D55384CF-D3E5-4CE5-813B-177FE021653DQ24792755-C6546210-EC7C-4C18-876A-9002901BAFEAQ24792952-9F8F84A4-828E-4990-B9D4-479D91E2691CQ24805264-B96B7523-C9A5-4109-B17D-C47F0A0CB036Q24810064-9662E02E-DB35-4CBC-BA0D-E46FCE6FC391Q26746279-6FF20CEA-BE2F-4EE5-BCF7-B6A2AD04F1F7Q26798492-477777EA-F57C-4F72-9273-9CFFE991AFC7Q26829529-B811FCAE-ACA1-4379-B7B9-FE4F226574EAQ26863499-0CDDC4A0-B462-4D66-AA88-68081FF27068Q27000731-DADA5330-30B6-48EC-816F-43F2AD4DAAF5Q28067396-4C0674E8-32C8-4C70-A977-7475A058496EQ28069452-67C25FB5-4D2D-4346-BCFD-E510294FE245Q28076399-C0E3CD79-AD7F-42B7-B097-4467C6D9D2F1Q28079661-34BEC13A-436F-4866-B3A5-0ED5974583DCQ28084204-96FDF895-2415-4994-8E11-FE29413ACAF3Q28116767-D3E9A894-C719-4C4F-A877-75EB92BA2A86Q28284661-2003612E-1B79-4858-B491-00242D6FDC95Q28344599-D32E520C-659C-4AC2-830A-02DA5B3DE82FQ28365592-BF2FEE9D-C468-4C60-A3FC-3CD91B21BB22Q28481738-003BCCC0-115C-488D-B04D-E19515E06B4CQ28596181-BD1486A7-01E8-4CA6-AE56-791EA8CD9CD2Q28729748-126B3D13-AEC2-4E2D-984E-361B2ABA1EF3Q30564150-0892212A-FEC7-4706-8233-024FC1608403Q30665284-1376FB0B-7AF8-476A-9D8F-13937FBBE5DFQ30700100-ED3F868C-1A9E-4E80-9428-7C696618CFA6Q33610637-3356958D-E8C6-407E-921B-C118CA662F81Q33651279-8B22FBEA-1067-470C-B5E2-F49A2F2E4F15Q33654016-C98D010E-021B-420B-A7AA-5166374E14ADQ33672134-43051ACF-0DA4-4322-AA91-1570E8481F67Q33694013-ED9D5AAF-1426-496E-A7F4-113A6E7971AAQ33698416-0A8B0C74-D42A-415C-9F4C-787799BB6BAFQ33715404-5012D8C8-E5A0-45B4-BC0E-A75EF970580F
P2860
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Plasma triglyceride level is a ...... ion-based prospective studies.
@en
Plasma triglyceride level is a ...... ion-based prospective studies.
@nl
type
label
Plasma triglyceride level is a ...... ion-based prospective studies.
@en
Plasma triglyceride level is a ...... ion-based prospective studies.
@nl
prefLabel
Plasma triglyceride level is a ...... ion-based prospective studies.
@en
Plasma triglyceride level is a ...... ion-based prospective studies.
@nl
P921
P1476
Plasma triglyceride level is a ...... tion-based prospective studies
@en
P2093
Hokanson JE
P304
P577
1996-04-01T00:00:00Z